Trademark Search in Canada

RENBIO

View On IC.GC.CA

REGISTERED

on 19 Feb 2024

Last Applicant/ Owned by

RENBIO INC.

30-02 48th AvenueLong Island City NY 11101

Serial Number

2118265 filed on 29^th Apr 2021

Registration Number

TMA1222089 registered on 19^th Feb 2024

Registration expiry Date

29^th Apr 2031

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

RENBIO

Trademark usage description

biological products, namely, dna circle, dna primers, linear dna and buffers for use in research and development of pharmaceuticals and for manufactur Read More

Classification Information

Class [001]
Biological products, namely, DNA circle, DNA primers, linear DNA and buffers for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals.

Classification kind code

Class [005]
Chemical preparations for gene delivery pharmaceuticals for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; gene therapy and prophylactic products, namely, pharmaceutical preparations for use in gene therapy and pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare autoimmune diseases and disorders, respiratory diseases, inflammatory connective tissue diseases, and blood disorders; pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare autoimmune diseases, respiratory diseases, inflammatory connective tissue diseases, and blood disorders; biological preparations for the treatment of cancer, autoimmune diseases, rare autoimmune diseases, respiratory diseases, inflammatory connective tissue diseases, and blood disorders; nucleic acid sequences, namely DNA for medical purposes; pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare autoimmune diseases, respiratory diseases, inflammatory connective tissue diseases, and blood disorders; pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare autoimmune diseases, respiratory diseases, inflammatory connective tissue diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals.

Classification kind code

Class [010]
Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators and intramuscular needle and electrode handpieces for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and waveform generators and intramuscular needle and electrode handpieces for the delivery of subdermal or intramuscular or intravenous drugs for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices comprised of pulse and waveform generators and intramuscular needle and electrode handpieces for the delivery of sub-dermal or intramuscular or intravenous drugs using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare autoimmune diseases, respiratory diseases, inflammatory connective tissue diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals.

Classification kind code

Class [042]
Medical and scientific research in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines.

Classification kind code

Mark Details

Serial Number

2118265

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 23^rd Jun 2022	Agent Changed
Submitted for opposition 256 on 2^th May 2022	Notification of Possible Opposition Sent
Submitted for opposition 80 on 21^st Apr 2022	Change of Title Registered
Submitted for opposition 135 on 14^th Oct 2021	Amendment to Application
Submitted for opposition 48 on 15^th Sept 2021	Agent Changed
Submitted for opposition 257 on 1^st Jul 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 1^st Jul 2021	Created
Submitted for opposition 31 on 1^st Jul 2021	Formalized
Submitted for opposition 30 on 29^th Apr 2021	Filed
Submitted for opposition 228 on 29^th Apr 2021	International Registration

RENBIO

Classification Information

Classification kind code

Classification kind code

Classification kind code

Class [042]Medical and scientific research in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Medical and scientific research in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines.